SOURCE: Skystar Bio-Pharmaceutical Company

Skystar Bio-Pharmaceutical Company

November 12, 2009 07:00 ET

Skystar Bio-Pharmaceuticals to Report Third Quarter 2009 Financial Results and Host Conference Call on Monday, November 16, 2009

XI'AN, CHINA--(Marketwire - November 12, 2009) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it will report its financial results for the third quarter of 2009, on Monday, November 16, 2009 at 8:00 a.m. Eastern time.

To participate in the conference call, please dial 888-549-7753 or 480-629-9858 from the US. Participants dialing in from China can access the call toll free by dialing 10800-852-1142 or 10800-152-1142. Investors may also access a live audio webcast of this conference call under "Events/Presentation" on the Investors Relations section of the Company's website at

A replay of the webcast will be available approximately two hours after the conclusion of the call. The webcast replay will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be made available until Monday, November 30, 2009. The audio replay can be accessed by dialing 800-406-7325 or 303-590-3030 and entering passcode 4184438#.

About Skystar Bio-Pharmaceutical Company

Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, micro-organisms, vaccines and feed additives) and over 170 products, with over 40 additional products in the developmental stage. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China. For additional information, please visit

To be added to the Company's email distribution for future news releases, please send your request to

Contact Information

  • Contacts
    The Piacente Group, Inc. (Investor Relations Counsel)
    Brandi Floberg
    (212) 481-2050
    Email Contact

    Skystar Bio-Pharmaceutical Company
    Scott Cramer
    Director - U.S. Representative
    (407) 645-4433
    Email Contact